文献速递乳房整形与再造美容整形

乳房假体历史回顾及其对诊断与现代手术规划的启示

Breast Implants: A Historical Review With Implications for Diagnosis and Modern Surgical Planning.
PubMed 文献 · Ann Plast Surg · 2021-01-01

文章按代际梳理乳房假体特征,涉及外形、质地、材料、包膜挛缩、破裂及公众风险认知等挑战,并提及1992年美国FDA对硅胶假体的禁令及其对诊断和手术规划的影响。

要点

  • 了解各代乳房假体特征有助于识别对应时代的并发症风险。
  • 1992年FDA禁令仅允许硅胶假体用于乳房再造、先天畸形或替换原有假体。
  • 历史知识可辅助新手整形外科医生进行现代手术规划与诊断。

核心结论

  • 掌握乳房假体的历史演变有助于理解各代假体相关的风险与结局,并服务于现代诊断和手术规划。

研究设计与样本

  • 本文为历史综述,按代际梳理乳房假体的特征及其对诊断和手术规划的启示。

主要发现

  • 现代乳房手术于1962年在美国随硅胶乳房假体引入而开始。
  • 1992年美国FDA禁止硅胶乳房假体,仅允许用于乳房再造、先天畸形或替换现有假体。
  • 该禁令引发了对假体及可能疾病表现的更多担忧。

临床怎么用

  • 临床中可依据假体代际特征辅助判断并发症风险并制定手术规划。
  • 对使用硅胶假体的患者需考虑1992年FDA禁令所限定的适应症范围。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Modern breast surgery was first introduced in the United States in 1962 with the use of silicone gel-filled breast implants. Over the past 6 decades, development of breast implants has been challenged by a variety of influencers including aesthetic appeal in shape, texture, and material; challenges in managing outcomes such as contracture, disease, and rupture; and public perception of risks associated with implants. In 1992, silicone breast prostheses were banned by the US Food and Drug Administration with exception for use in breast reconstruction, congenital deformities, or to replace existing implants.The ban led to heightened concerns about implants and possible disease manifestations. Knowledge of the historical evolution of breast prostheses is useful for understanding the associated risks and outcomes unique to each breast implant era. This article aimed to explore characteristics of breast implants by generation, with implications for diagnosis and assistance to modern surgical planning for novice plastic surgeons.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Powell LE, Andersen ES, Nigro LC, et al. Breast Implants: A Historical Review With Implications for Diagnosis and Modern Surgical Planning. Ann Plast Surg. 2021. PMID: 34253702. doi:10.1097/SAP.0000000000002731

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。